vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.

Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $24.7M, roughly 1.1× Editas Medicine, Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -22.7%, a 4.7% gap on every dollar of revenue. On growth, Maison Solutions Inc. posted the faster year-over-year revenue change (-10.9% vs -19.2%). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 42.5%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.

EDIT vs MSS — Head-to-Head

Bigger by revenue
MSS
MSS
1.1× larger
MSS
$27.6M
$24.7M
EDIT
Growing faster (revenue YoY)
MSS
MSS
+8.2% gap
MSS
-10.9%
-19.2%
EDIT
Higher net margin
MSS
MSS
4.7% more per $
MSS
-18.0%
-22.7%
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
42.5%
MSS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
EDIT
EDIT
MSS
MSS
Revenue
$24.7M
$27.6M
Net Profit
$-5.6M
$-5.0M
Gross Margin
23.4%
Operating Margin
-31.3%
-4.9%
Net Margin
-22.7%
-18.0%
Revenue YoY
-19.2%
-10.9%
Net Profit YoY
87.6%
-1840.5%
EPS (diluted)
$0.03
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
MSS
MSS
Q4 25
$24.7M
$27.6M
Q3 25
$7.5M
$27.2M
Q2 25
$3.6M
$34.4M
Q1 25
$4.7M
$32.3M
Q4 24
$30.6M
$29.4M
Q3 24
$61.0K
$28.2M
Q2 24
$513.0K
$16.9M
Q1 24
$1.1M
$13.6M
Net Profit
EDIT
EDIT
MSS
MSS
Q4 25
$-5.6M
$-5.0M
Q3 25
$-25.1M
$-1.5M
Q2 25
$-53.2M
$-287.4K
Q1 25
$-76.1M
$1.0M
Q4 24
$-45.4M
$-256.0K
Q3 24
$-62.1M
$700.9K
Q2 24
$-67.6M
$-2.8M
Q1 24
$-62.0M
$-549.0K
Gross Margin
EDIT
EDIT
MSS
MSS
Q4 25
23.4%
Q3 25
24.1%
Q2 25
9.5%
Q1 25
21.8%
Q4 24
26.9%
Q3 24
28.9%
Q2 24
13.0%
Q1 24
23.4%
Operating Margin
EDIT
EDIT
MSS
MSS
Q4 25
-31.3%
-4.9%
Q3 25
-325.4%
0.7%
Q2 25
-1440.6%
-15.9%
Q1 25
-1635.1%
3.7%
Q4 24
-152.2%
3.2%
Q3 24
-107649.2%
7.3%
Q2 24
-14016.2%
-14.4%
Q1 24
-5902.3%
-2.3%
Net Margin
EDIT
EDIT
MSS
MSS
Q4 25
-22.7%
-18.0%
Q3 25
-333.0%
-5.7%
Q2 25
-1487.8%
-0.8%
Q1 25
-1633.5%
3.1%
Q4 24
-148.3%
-0.9%
Q3 24
-101870.5%
2.5%
Q2 24
-13178.8%
-16.4%
Q1 24
-5458.1%
-4.0%
EPS (diluted)
EDIT
EDIT
MSS
MSS
Q4 25
$0.03
$-0.23
Q3 25
$-0.28
$-0.08
Q2 25
$-0.63
$-0.02
Q1 25
$-0.92
$0.06
Q4 24
$-0.55
$-0.01
Q3 24
$-0.75
$0.04
Q2 24
$-0.82
$-0.16
Q1 24
$-0.76
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
MSS
MSS
Cash + ST InvestmentsLiquidity on hand
$146.6M
Total DebtLower is stronger
$2.6M
Stockholders' EquityBook value
$27.3M
$11.6M
Total Assets
$186.5M
$75.4M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
MSS
MSS
Q4 25
$146.6M
Q3 25
$165.6M
$1.1M
Q2 25
$178.5M
$775.4K
Q1 25
$221.0M
$445.4K
Q4 24
$269.9M
$355.7K
Q3 24
$265.1M
$588.9K
Q2 24
$279.1M
$2.1M
Q1 24
$296.2M
$9.4M
Total Debt
EDIT
EDIT
MSS
MSS
Q4 25
$2.6M
Q3 25
$2.6M
Q2 25
$2.6M
Q1 25
Q4 24
$57.4M
Q3 24
$2.5M
Q2 24
$2.6M
Q1 24
$2.6M
Stockholders' Equity
EDIT
EDIT
MSS
MSS
Q4 25
$27.3M
$11.6M
Q3 25
$13.5M
$10.1M
Q2 25
$19.2M
$11.7M
Q1 25
$62.4M
$12.0M
Q4 24
$134.3M
$10.9M
Q3 24
$175.6M
$11.2M
Q2 24
$232.0M
$10.5M
Q1 24
$294.4M
$13.3M
Total Assets
EDIT
EDIT
MSS
MSS
Q4 25
$186.5M
$75.4M
Q3 25
$201.8M
$73.3M
Q2 25
$210.6M
$77.4M
Q1 25
$263.7M
$82.7M
Q4 24
$341.6M
$82.7M
Q3 24
$327.6M
$82.1M
Q2 24
$384.8M
$82.4M
Q1 24
$440.3M
$44.2M
Debt / Equity
EDIT
EDIT
MSS
MSS
Q4 25
0.22×
Q3 25
0.26×
Q2 25
0.22×
Q1 25
Q4 24
0.43×
Q3 24
0.23×
Q2 24
0.24×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
MSS
MSS
Operating Cash FlowLast quarter
$-36.4M
$-1.7M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
MSS
MSS
Q4 25
$-36.4M
$-1.7M
Q3 25
$-30.8M
$1.1M
Q2 25
$-50.2M
$-1.6M
Q1 25
$-47.8M
$1.7M
Q4 24
$-50.8M
$1.1M
Q3 24
$-52.6M
$3.6M
Q2 24
$-57.1M
$-2.6M
Q1 24
$-49.9M
$-1.4M
Free Cash Flow
EDIT
EDIT
MSS
MSS
Q4 25
$-36.4M
Q3 25
$-31.3M
Q2 25
Q1 25
$-47.9M
Q4 24
$-51.3M
Q3 24
$-55.5M
Q2 24
$-60.6M
Q1 24
$-51.7M
FCF Margin
EDIT
EDIT
MSS
MSS
Q4 25
-147.3%
Q3 25
-414.6%
Q2 25
Q1 25
-1028.6%
Q4 24
-167.6%
Q3 24
-90998.4%
Q2 24
-11804.3%
Q1 24
-4558.9%
Capex Intensity
EDIT
EDIT
MSS
MSS
Q4 25
0.2%
Q3 25
5.7%
Q2 25
0.0%
Q1 25
2.4%
Q4 24
1.8%
Q3 24
4788.5%
Q2 24
681.1%
Q1 24
164.8%
Cash Conversion
EDIT
EDIT
MSS
MSS
Q4 25
Q3 25
Q2 25
Q1 25
1.66×
Q4 24
Q3 24
5.12×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

MSS
MSS

Perishables$14.4M52%
Nonperishables$13.2M48%

Related Comparisons